Epigenetic inactivation of the SFRP1 gene in esophageal squamous cell carcinoma

Digestive Diseases and Sciences

Volumn 56, Issue 11, 2011, Pages 3195-3203

  Meng, Ying ^a   Wang, Qing Gang ^a   Wang, Jun Xiong ^a   Zhu, Sheng Tao ^a   Jiao, Yue ^a   Li, Peng ^a   Zhang, Shu Tian ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Acetylation; DNA methylation; Esophageal squamous cell carcinoma; SFRP1

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; MESSENGER RNA; SECRETED FRIZZLED RELATED PROTEIN 1; TRICHOSTATIN A;

ARTICLE; CANCER CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EPIGENETICS; EPITHELIUM CELL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE EXPRESSION; GENE INACTIVATION; GENE SEQUENCE; GENE SILENCING; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; GENE SILENCING; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS;

EID: 82555192553     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1734-7     Document Type: Article

References (48)

1. M Guo J Ren MG House, et al. 2006 Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus Clin Cancer Res 12 4515 4522 16899597 10.1158/1078-0432.CCR-05-2858 1:CAS:528:DC%2BD28XnvVGksr4%3D (Pubitemid 44297800)
2. G Corrao V Bagnardi A Zambon C La Vecchia 2004 A meta-analysis of alcohol consumption and the risk of 15 diseases Prev Med 38 613 619 15066364 10.1016/j.ypmed.2003.11.027 (Pubitemid 38452887)
3. LS Engel WH Chow TL Vaughan, et al. 2003 Population attributable risks of esophageal and gastric cancers J Natl Cancer Inst 95 1404 1413 13130116 (Pubitemid 37220460)
4. Y Yokokawa S Ohta J Hou, et al. 1999 Ecological study on the risks of esophageal cancer in ci-xian, china: the importance of nutritional status and the use of well water Int J Cancer 83 620 624 10521797 10.1002/(SICI)1097- 0215(19991126)83:5<620::AID-IJC9>3.0.CO;2-W 1:STN:280:DyaK1Mvlt1yqtg%3D%3D (Pubitemid 29508040)
5. N Aragones R Ramis M Pollan, et al. 2007 Oesophageal cancer mortality in Spain: a spatial analysis BMC Cancer 7 3 17201909 10.1186/1471-2407-7-3 (Pubitemid 46218597)
6. JG Herman SB Baylin 2003 Gene silencing in cancer in association with promoter hypermethylation N Engl J Med 349 2042 2054 14627790 10.1056/NEJMra023075 1:CAS:528:DC%2BD3sXptFKmu7s%3D (Pubitemid 37448928)
7. T Ushijima 2007 Epigenetic field for cancerization J Biochem Mol Biol 40 142 150 17394762 10.5483/BMBRep.2007.40.2.142 1:CAS:528:DC%2BD2sXkt1Krtbg%3D (Pubitemid 46515191)
8. T Ishii J Murakami K Notohara, et al. 2007 Oesophageal squamous cell carcinoma may develop within a background of accumulating DNA methylation in normal and dysplastic mucosa Gut 56 13 19 16785283 10.1136/gut.2005.089813 1:CAS:528:DC%2BD2sXhtF2qs7c%3D (Pubitemid 46044883)
9. J Ying H Li TJ Seng, et al. 2006 Functional epigenetics identifies a protocadherin pcdh10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation Oncogene 25 1070 1080 16247458 10.1038/sj.onc.1209154 1:CAS:528:DC%2BD28XhsVehsrY%3D (Pubitemid 43277014)
10. Y Wang J Li Y Cui, et al. 2009 Cmtm3, located at the critical tumor suppressor locus 16q22.1, is silenced by cpg methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis Cancer Res 69 5194 5201 19509237 10.1158/0008-5472.CAN-08-3694 1:CAS:528:DC%2BD1MXnt1equ70%3D
11. J Yu Q Tao KF Cheung, et al. 2008 Epigenetic identification of ubiquitin carboxyl-terminal hydrolase l1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors Hepatology 48 508 518 18666234 10.1002/hep.22343 1:CAS:528:DC%2BD1cXhtVCqt7vN
12. MV Brock CM Hooker E Ota-Machida, et al. 2008 DNA methylation markers and early recurrence in stage i lung cancer N Engl J Med 358 1118 1128 18337602 10.1056/NEJMoa0706550 1:CAS:528:DC%2BD1cXjt1aiurc%3D (Pubitemid 351398486)
13. KM Cadigan R Nusse 1997 Wnt signaling: a common theme in animal development Genes Dev 11 3286 3305 9407023 10.1101/gad.11.24.3286 1:CAS:528:DyaK1cXivFaltg%3D%3D (Pubitemid 28023954)
14. WM Zhang L Lo Muzio C Rubini G Yan 2005 Effect of wnt-1 on beta-catenin expression and its relation to ki-67 and tumor differentiation in oral squamous cell carcinoma Oncol Rep 13 1095 1099 15870927 1:CAS:528:DC%2BD2MXltV2lu7w%3D
15. G Clement R Braunschweig N Pasquier FT Bosman J Benhattar 2006 Alterations of the wnt signaling pathway during the neoplastic progression of Barrett's esophagus Oncogene 25 3084 3092 16407829 10.1038/sj.onc.1209338 1:CAS:528:DC%2BD28Xks1Orsb0%3D (Pubitemid 43780474)
16. H Suzuki DN Watkins KW Jair, et al. 2004 Epigenetic inactivation of sfrp genes allows constitutive wnt signaling in colorectal cancer Nat Genet 36 417 422 15034581 10.1038/ng1330 1:CAS:528:DC%2BD2cXis1ahtrY%3D (Pubitemid 38437267)
17. M Nojima H Suzuki M Toyota, et al. 2007 Frequent epigenetic inactivation of sfrp genes and constitutive activation of wnt signaling in gastric cancer Oncogene 26 4699 4713 17297461 10.1038/sj.onc.1210259 1:CAS:528: DC%2BD2sXnsFOisrk%3D (Pubitemid 47067406)
18. PW Finch X He MJ Kelley, et al. 1997 Purification and molecular cloning of a secreted, frizzled-related antagonist of wnt action Proc Natl Acad Sci USA 94 6770 6775 9192640 10.1073/pnas.94.13.6770 1:CAS:528:DyaK2sXktF2rtbg%3D (Pubitemid 27281939)
19. MT Chung HK Sytwu MD Yan, et al. 2009 Promoter methylation of sfrps gene family in cervical cancer Gynecol Oncol 112 301 306 19038436 10.1016/j.ygyno.2008.10.004 1:CAS:528:DC%2BD1MXntFersQ%3D%3D
20. CJ Marsit MD McClean CS Furniss KT Kelsey 2006 Epigenetic inactivation of the sfrp genes is associated with drinking, smoking and hpv in head and neck squamous cell carcinoma Int J Cancer 119 1761 1766 16708382 10.1002/ijc.22051 1:CAS:528:DC%2BD28Xps1Snsrc%3D (Pubitemid 44356831)
21. GM Caldwell C Jones K Gensberg, et al. 2004 The wnt antagonist sfrp1 in colorectal tumorigenesis Cancer Res 64 883 888 14871816 10.1158/0008-5472.CAN- 03-1346 1:CAS:528:DC%2BD2cXhtFCgtbw%3D (Pubitemid 38176888)
22. E Smith NJ De Young SJ Pavey, et al. 2008 Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma Mol Cancer 7 75 18831746 10.1186/1476-4598-7-75
23. J Veeck D Niederacher H An, et al. 2006 Aberrant methylation of the wnt antagonist sfrp1 in breast cancer is associated with unfavourable prognosis Oncogene 25 3479 3488 16449975 10.1038/sj.onc.1209386 1:CAS:528: DC%2BD28XlsVersbw%3D (Pubitemid 43877051)
24. Y He Y Wang P Li, et al. 2011 Identification of gpx3 epigenetically silenced by cpg methylation in human esophageal squamous cell carcinoma Dig Dis Sci 56 681 688 20725785 10.1007/s10620-010-1369-0 1:CAS:528:DC%2BC3MXit1GqtrY%3D
25. K Milde-Langosch AM Bamberger G Rieck B Kelp T Loning 2001 Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype Breast Cancer Res Treat 67 61 70 11518467 10.1023/A:1010623308275 1:CAS:528:DC%2BD3MXms1SiurY%3D (Pubitemid 32703389)
26. KP Sundararaj RE Wood S Ponnusamy, et al. 2004 Rapid shortening of telomere length in response to ceramide involves the inhibition of telomere binding activity of nuclear glyceraldehyde-3-phosphate dehydrogenase J Biol Chem 279 6152 6162 14630908 10.1074/jbc.M310549200 1:CAS:528:DC%2BD2cXhtFCjtrg%3D (Pubitemid 38220648)
27. J He T Sheng AA Stelter, et al. 2006 Suppressing wnt signaling by the hedgehog pathway through sfrp-1 J Biol Chem 281 35598 35602 17035233 10.1074/jbc.C600200200 1:CAS:528:DC%2BD28Xht1ajtrrN (Pubitemid 46041289)
28. SL Berger 2007 The complex language of chromatin regulation during transcription Nature 447 407 412 17522673 10.1038/nature05915 1:CAS:528:DC%2BD2sXlsFOgsrc%3D (Pubitemid 46816746)
29. JE Armes F Hammet M de Silva, et al. 2004 Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers Oncogene 23 5697 5702 15184884 10.1038/sj.onc.1207740 1:CAS:528:DC%2BD2cXlvVehsLw%3D (Pubitemid 39093049)
30. Y Awakura E Nakamura N Ito T Kamoto O Ogawa 2008 Methylation-associated silencing of sfrp1 in renal cell carcinoma Oncol Rep 20 1257 1263 18949430 1:CAS:528:DC%2BD1cXhsVaqtr3I
31. I Ali P Rafiee Y Zheng, et al. 2009 Intramucosal distribution of wnt signaling components in human esophagus J Clin Gastroenterol 43 327 337 19309775 10.1097/MCG.0b013e31816256ff
32. SB Baylin 2002 Mechanisms underlying epigenetically mediated gene silencing in cancer Semin Cancer Biol 12 331 337 12191632 10.1016/S1044-579X(02) 00053-6 1:CAS:528:DC%2BD38Xmt12qt78%3D
33. J Huang YL Zhang XM Teng, et al. 2007 Down-regulation of sfrp1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma BMC Cancer 7 126 17626620 10.1186/1471-2407-7-126 (Pubitemid 47226095)
34. D Lodygin A Epanchintsev A Menssen J Diebold H Hermeking 2005 Functional epigenomics identifies genes frequently silenced in prostate cancer Cancer Res 65 4218 4227 15899813 10.1158/0008-5472.CAN-04-4407 1:CAS:528: DC%2BD2MXktlSmtrk%3D (Pubitemid 40775660)
35. N Steele P Finn R Brown JA Plumb 2009 Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo Br J Cancer 100 758 763 19259094 10.1038/sj.bjc.6604932 1:CAS:528:DC%2BD1MXisFentL4%3D
36. EE Cameron KE Bachman S Myohanen JG Herman SB Baylin 1999 Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer Nat Genet 21 103 107 9916800 10.1038/5047 1:CAS:528:DyaK1MXltlWjtA%3D%3D (Pubitemid 29036293)
37. AR Karpf DA Jones 2002 Reactivating the expression of methylation silenced genes in human cancer Oncogene 21 5496 5503 12154410 10.1038/sj.onc.1205602 1:CAS:528:DC%2BD38XlslSqt70%3D (Pubitemid 34983484)
38. SA Belinsky DM Klinge CA Stidley, et al. 2003 Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer Cancer Res 63 7089 7093 14612500 1:CAS:528:DC%2BD3sXovVGlsLk%3D (Pubitemid 37413444)
39. C Zhang H Li G Zhou, et al. 2007 Transcriptional silencing of the tms1/asc tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells J Pathol 212 134 142 17471463 10.1002/path.2173 1:CAS:528:DC%2BD2sXnt1Gkt7s%3D (Pubitemid 46852091)
40. JA Plumb N Steele PW Finn R Brown 2004 Epigenetic approaches to cancer therapy Biochem Soc Trans 32 1095 1097 15506976 10.1042/BST0321095 1:CAS:528:DC%2BD2cXptVSksro%3D (Pubitemid 39655556)
41. P Chiurazzi MG Pomponi R Pietrobono, et al. 1999 Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the fmr1 gene Hum Mol Genet 8 2317 2323 10545613 10.1093/hmg/8.12.2317 1:CAS:528:DyaK1MXnsVGnsbY%3D (Pubitemid 29525348)
42. F Fuks WA Burgers A Brehm L Hughes-Davies T Kouzarides 2000 DNA methyltransferase dnmt1 associates with histone deacetylase activity Nat Genet 24 88 91 10615135 10.1038/71750 1:CAS:528:DC%2BD3cXks1eltg%3D%3D (Pubitemid 30041428)
43. KD Robertson S Ait-Si-Ali T Yokochi, et al. 2000 Dnmt1 forms a complex with rb, e2f1 and hdac1 and represses transcription from e2f-responsive promoters Nat Genet 25 338 342 10888886 10.1038/77124 1:CAS:528: DC%2BD3cXkvFKkt7Y%3D (Pubitemid 30437325)
44. N Cervoni M Szyf 2001 Demethylase activity is directed by histone acetylation J Biol Chem 276 40778 40787 11524416 10.1074/jbc.M103921200 1:CAS:528:DC%2BD3MXosVKhurg%3D
45. G Egger AM Aparicio SG Escobar PA Jones 2007 Inhibition of histone deacetylation does not block resilencing of p16 after 5-aza-2-deoxycytidine treatment Cancer Res 67 346 353 17210717 10.1158/0008-5472.CAN-06-2845 1:CAS:528:DC%2BD2sXisFSrug%3D%3D (Pubitemid 46142794)
46. F Fuks WA Burgers N Godin M Kasai T Kouzarides 2001 Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription EMBO J 20 2536 2544 11350943 10.1093/emboj/20.10.2536 1:CAS:528:DC%2BD3MXktFensr8%3D (Pubitemid 32452872)
47. P Kapoor-Vazirani JD Kagey DR Powell PM Vertino 2008 Role of hmof-dependent histone h4 lysine 16 acetylation in the maintenance of tms1/asc gene activity Cancer Res 68 6810 6821 18701507 10.1158/0008-5472.CAN-08-0141 1:CAS:528:DC%2BD1cXpslKmt7k%3D
48. J Hu A Dong V Fernandez-Ruiz, et al. 2009 Blockade of wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma Cancer Res 69 6951 6959 19690140 10.1158/0008-5472.CAN-09-0541 1:CAS:528:DC%2BD1MXhtVOmtL3P